Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
NetSol Technologies
NTWK
$48.3M
| $2.9M | ﹤0.01% |
513,813
+9,800
| +2% | +$54.7K |
|
|
IVAC
2077
DELISTED
Intevac Inc
IVAC
| $2.88M | ﹤0.01% |
549,409
+66,717
| +14% | +$333K |
|
|
AGRX
2078
DELISTED
Agile Therapeutics
AGRX
| $2.88M | ﹤0.01% |
1,214
+87
| +8% | +$214K |
|
|
BKI
2079
DELISTED
Black Knight, Inc. Common Stock
BKI
| $2.88M | ﹤0.01% |
47,078
-66,100
| -58% | -$4.1M |
|
|
CDOR
2080
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
| $2.87M | ﹤0.01% |
260,130
+128,715
| +98% | +$1.35M |
|
|
DQ
2081
Daqo New Energy
DQ
$991M
| $2.86M | ﹤0.01% |
+310,500
| New | +$2.84M |
|
2082
Urban One Class D
UONEK
$23.4M
| $2.85M | ﹤0.01% |
148,365
+2,794
| +2% | +$55.5K |
|
|
NSTG
2083
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.84M | ﹤0.01% |
131,500
-48,890
| -27% | -$1.3M |
|
|
MTOR
2084
DELISTED
MERITOR, Inc.
MTOR
| $2.84M | ﹤0.01% |
153,400
+88,800
| +137% | +$1.8M |
|
2085
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.93B
| $2.84M | ﹤0.01% |
95,700
+82,200
| +609% | +$2.42M |
|
|
SCX
2086
DELISTED
The L.S. Starrett Company
SCX
| $2.84M | ﹤0.01% |
489,221
+58,076
| +13% | +$340K |
|
2087
HUTCHMED
HCM
$2.12B
| $2.83M | ﹤0.01% |
158,800
+111,400
| +235% | +$2.32M |
|
|
UBFO
2088
DELISTED
United Security Bancshares
UBFO
| $2.83M | ﹤0.01% |
268,712
+17,874
| +7% | +$190K |
|
|
ERF
2089
DELISTED
Enerplus Corporation
ERF
| $2.83M | ﹤0.01% |
379,757
+299,100
| +371% | +$2.06M |
|
|
ELGX
2090
DELISTED
Endologix Inc
ELGX
| $2.82M | ﹤0.01% |
711,268
+97,362
| +16% | +$566K |
|
|
SHOS
2091
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
| $2.82M | ﹤0.01% |
819,548
+156,255
| +24% | +$462K |
|
|
FRBK
2092
DELISTED
Republic First Bancorp Inc
FRBK
| $2.82M | ﹤0.01% |
670,933
+273,400
| +69% | +$1.19M |
|
2093
Toro Company
TTC
$9.37B
| $2.81M | ﹤0.01% |
38,400
-68,900
| -64% | -$4.92M |
|
2094
SandRidge Energy
SD
$520M
| $2.8M | ﹤0.01% |
596,600
+372,900
| +167% | +$2.14M |
|
|
CHMA
2095
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $2.8M | ﹤0.01% |
566,423
+154,540
| +38% | +$876K |
|
2096
Gentherm
THRM
$1.35B
| $2.78M | ﹤0.01% |
67,764
+36,200
| +115% | +$1.43M |
|
2097
Valhi
VHI
$459M
| $2.78M | ﹤0.01% |
122,052
+375
| +0.3% | +$9.58K |
|
2098
Cumberland Pharmaceuticals
CPIX
$117M
| $2.78M | ﹤0.01% |
469,138
+27,561
| +6% | +$153K |
|
|
ROCC
2099
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.78M | ﹤0.01% |
95,600
-35,200
| -27% | -$1.09M |
|
|
RDUS
2100
DELISTED
Radius Health, Inc.
RDUS
| $2.78M | ﹤0.01% |
+107,900
| New | +$2.64M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.